SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

27 hedge funds and large institutions have $2.55M invested in Seelos Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UIC
1
Uniplan Investment Counsel
Wisconsin
$1.01M
2
SM
2
Sabby Management
Florida
$249K
3
TAM
3
Tocqueville Asset Management
New York
$94K
4
1CM
4
1492 Capital Management
Wisconsin
$74K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$158K

Top Sellers

1
MWP
1
MYCIO Wealth Partners
Pennsylvania
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$529K
3
Squarepoint
3
Squarepoint
New York
$9K
Name Market Value Shares Shares
Change 		Shares
Change %
Barclays
26
Barclays
United Kingdom
– – -1 Closed
LFG
27
Larson Financial Group
Missouri
$0 2 – –
HI
28
Hudock Inc
Pennsylvania
$0 1 – –
JPMorgan Chase & Co
29
JPMorgan Chase & Co
New York
$0 16 – –
Group One Trading
30
Group One Trading
Illinois
$0 17 – –
CFGS
31
Concourse Financial Group Securities
Alabama
– – – –
Wells Fargo
32
Wells Fargo
California
$0 203 +170 +515%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$0 449 +449 New
1
2